Neurological clinical presentation of long covid syndrome

Authors

  • Oxana GROSU Diomid Gherman Institute of Neurology and Neurosurgery
  • Cornelia TURCAN Diomid Gherman Institute of Neurology and Neurosurgery; Nicolae Testemițanu State University of Medicine and Pharmacy
  • Lilia ROTARU Diomid Gherman Institute of Neurology and Neurosurgery
  • Stela ODOBESCU Diomid Gherman Institute of Neurology and Neurosurgery
  • Ion MOLDOVANU Diomid Gherman Institute of Neurology and Neurosurgery

DOI:

https://doi.org/10.52692/1857-0011.2024.3-80.04

Keywords:

long COVID syndrome, fatigue, neurological disorders, neurocognitive disorders

Abstract

Patients who have suffered from COVID-19 after a certain time report a wide range of new or persistent symptoms (symptoms that persist for at least 12 weeks) called “long COVID-19 syndrome”.Aim: Narrative review regarding post-Covid-19 symptomatology to establish the clinical variability. Material and Methods: To achieve the purpose of the study, a systematic analysis of literature data on the given topic was performed. Thus, scientific sources were studied in the scientific citation databases PubMed, Google Scholar, Web of Science, eLibrary. Results and discussions: According to the studies analyzed, most patients most often manifest fatigue, cognitive disorders and sleep disorders, less often present other neurological disorders (headache, anxiety, depression, etc.). Patients with long COVID-19 syndrome report sleep disorders such as insomnia or drowsiness. These people have greater difficulty falling asleep at the desired time and also waking up at the desired time. In some patients, sleep disorders were present even after 12 months after Covid-19, with a negative impact on the quality of life of patients. Headache is one of the earliest and most common symptoms of long COVID-19 syndrome. The presence of headache in the acute phase of Covid-19 infection was considered a positive prognosis, being associated with lower severity and mortality. Headache may persist to a significant extent in the long term. Depression and anxiety may be more a result of the severity of the illness and psychological trauma following the pandemic than a result of the viral infection. Anxiety and depression have significant long-term consequences. Conclusions: Long COVID syndrome is a complex condition with prolonged heterogeneous symptoms. Our study suggests the presence of fatigue, cognitive impairment, sleep disorders, headache, anxiety, and depression in the neurological symptomatology of long Covid syndrome. The persistence of long-term symptomatology highlights the importance of a holistic and continuous approach to better understand the impact of this disease on health and establish appropriate management.

Author Biographies

Oxana GROSU, Diomid Gherman Institute of Neurology and Neurosurgery

PhD in Medical Sciences, Scientific Researcher

Cornelia TURCAN, Diomid Gherman Institute of Neurology and Neurosurgery; Nicolae Testemițanu State University of Medicine and Pharmacy

medical resident

Lilia ROTARU, Diomid Gherman Institute of Neurology and Neurosurgery

PhD in Medical Sciences, Scientific Researcher

Stela ODOBESCU, Diomid Gherman Institute of Neurology and Neurosurgery

Dr. Habil. in Medical Sciences, Research Associate Professor

Ion MOLDOVANU, Diomid Gherman Institute of Neurology and Neurosurgery

Dr. Habil. in Medical Sciences, University Professor

References

Golden N, Shahab A, Mahadewa TGB, Mardhika PE, Awyono S, Putra1MD , Tombeng M, Scalenus Syndrome: A Literature Review. Open Access Macedonian Journal of Medical Sciences. 2021, 9(F), pp. 6-12.

Davidson EJ, Tan ET, Sneag DB. Magnetic resonance neurography in the diagnosis of neurological subtypes of thoracic outlet syndrome. Muscle Nerve. 2024.

Chen D, Gong W, Wang J, Hao J, Zhao R, Zheng M. Diagnosis of thoracic outlet syndrome with the lower trunk compression of brachial plexus by high- frequency ultrasonography. BMC Musculoskelet Disord. 2023, 24(1), p. 690.

Hooper TL, Denton J, McGalliard MK, Brismée JM, Sizer PS. Thoracic outlet syndrome: a controversial clinical condition. Part 1: anatomy, and clinical examination/diagnosis. Journal of Manual & Manipulative Therapy. 2010, 18(2), pp. 74-83.

Jones MR, Prabhakar A, Viswanath O, Urits I, Green JB, Kendrick JB, et al, Thoracic outlet syndrome: A comprehensive review of pathophysiology, diagnosis, and treatment. Pain Ther. 2019, 8(1), pp. 5-18.

Sanders RJ, Hammond SL, Rao NM, Diagnosis of thoracic outlet syndrome. J Vasc Surg. 2007, 46(3), pp. 601-4.

Spurling RG, Bradford FK, Scalenus neurocirculatory compression. Ann Surg. 1938, 107(5), pp. 708-15.

Tanna JF. Scalenotomy: An analysis of eleven cases done for scalenus anticus syndrome. Ann Surg. 1947;125(1):80-8.

Vanti C, Natalini L, Romeo A, Tosarelli D, Pillastrini P. Conservative treatment of thoracic outlet syndrome.Eura medicophys. 2007, 43, pp. 55-70.

Demondion X, Herbinet P, Van Sint Jan S, Boutry N, Chantelot C, Cotten A. Imaging assessment of thoracic outlet syndrome. RadioGraphics. 2006, 26(6), pp. 1735–50.

Campbell WW, Landau ME, Controversial entrapment neuropathies. Neurosurg Clin N Am. 2008, 19(4), pp. 597-608.

César Fernàndez et al.; Manual Therapy for Musculoskeletal Pain Syndromes Elsevier, 2016.

Lindgren KA. Thoracic outlet syndrome. International Musculoskeletal Medicine. 2010, 32(1), pp. 17-24.

Bilbey H, Luoma A, Muller L, Connell G. Thoracic radiology outlet syndrome: Evaluation with CT. Radiology. 1989, 171(1), pp. 381-4.

Christo PJ. CT-Guided injection of the anterior and middle scalene muscles: Technique and complications. AJNR Am J Neuroradiol. 2011, 32(3), pp. 495-500.

Weaver ML, Lum YW. New diagnostic and treatment modalities for neurogenic thoracic outlet syndrome. Diagnostics. 2017, 7(2), p. 28.

Dengler NF, Pedro MT, Kretschmer T, Heinen C, Rosahl SK, and Antoniadis G, Neurogenic Thoracic Outlet Syndrome Dtsch Arztebl Int. 2022, 119(43), pp. 735-742.

Weaver ML, Lum YW. New Diagnostic and Treatment Modalities for Neurogenic Thoracic Outlet Syndrome. Diagnostics (Basel). 2017, 7(2), p. 28.

Finlayson HC, O’Connor RJ, Brasher PMA, Travlos Botulinum toxin injection for management of thoracic outlet syndrome: a double-blind, randomized, controlled trial. Pain. 2011, 152(9), pp. 2023-2028.

Lewis M, Prashar A, Toms A, Armon M, Malcolm P The diagnosis of thoracic outlet syndrome. 2014, pp. 113-120.

Balderman J, Abuirqeba AA, Eichaker L, Pate C, Earley JA, Bottros MM, Jayarajan SN, Thompson RW. Physical therapy management, surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome. J Vasc Surg. 2019, 70(3), pp. 832-841. doi: 10.1016/j.jvs.2018.12.027.

Lee J, Laker S, Fredericson M. Thoracic outlet syndrome. PM R. 2010, 2(1), pp. 64-70.

Published

2025-09-09

Issue

Section

Research Article